Business

Analyst’s Review to Watch: Dextera Surgical Inc (NASDAQ:DXTR)

Dextera Surgical Inc (NASDAQ:DXTR) shares traded -47.33% down during most recent session to reach at the closing price of $0.22. The stock exchanged hands 4.16 Million shares versus average trading capacity of 373.31 Million shares, yielding a market cap of $1.97 Million. Wall Street analysts covering the stock are projecting that the stock will reach $3.5 within the next 52-weeks. The mean target projections are based on 1 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Dextera Surgical Inc (NASDAQ:DXTR) high price target of $3.5 and with a conservative view have low price target of $3.5.

On the other hand the company has Relative Strength Index (RSI 14) of 18.88 along with Average True Range (ATR 14) of 0.14, Consequently Dextera Surgical Inc (NASDAQ:DXTR)’s weekly and monthly volatility is 25.48%, 19.53% respectively. The company’s beta value is at -0.73.

In terms of Buy, Sell or Hold recommendations, Dextera Surgical Inc (NASDAQ:DXTR) has analysts’ mean recommendation of 2. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

Analysts who have weighed in on projected earnings growth are expecting that Dextera Surgical Inc (NASDAQ:DXTR) will report earnings of $-0.3 for the current quarter on or around 8/8/17, however the company’s high EPS estimates are $-0.3 and low estimates are $-0.3. However the company reported $-0.48 earnings per share for the same quarter during last year.

Previously Dextera Surgical Inc (NASDAQ:DXTR) reported $-0.5 earnings per share (EPS) for the quarter, missing the consensus estimate of $-0.49 by $-0.01. The company posted an earnings surprise of -2%.

Dextera Surgical Inc (NASDAQ:DXTR)’s revenue estimates for the current quarter are $1.29 Million according to 1 number of analysts, for the current quarter the company has high revenue estimates of $1.29 Million in contradiction of low revenue estimates of $1.29 Million. For the current year the company’s revenue estimates are $3.65 Million compared to low analyst estimates of $3.65 Million and high estimates of $3.65 Million according to 1 number of analysts.

Currently Dextera Surgical Inc (NASDAQ:DXTR)’s shares owned by insiders are 0.3%, whereas shares owned by institutional owners are 39.9%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded 0.15%.

Dextera Surgical Inc (NASDAQ:DXTR) 52-week high price stands3.23 and low price stands0.41, its price distance from 52-week high is -93.15% while its distance from 52-week low price is -46.05%. The stock hit its 52-week high on 06/03/16, and 52-week low on 05/12/17.

Dextera Surgical Inc (NASDAQ:DXTR)’s trailing twelve month revenues are $3.9 Million, whereas its price to sales ratio for the same period is 0.97. Its book value per share for the most recent quarter is $-2.36 while its price to book ratio for the same period is 0, as for as the company’s cash per share for the most recent quarter is $0.15, however its price to cash per share ratio for the same period is 1.52. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.

Previous ArticleNext Article